CLPT · ClearPoint Neuro, Inc.
$15.34
-0.08 (-0.52%)
At close · Aug 14
Market Cap
$467.93M
Shares
30.50M
Positioning
Aug 21, 2026 · 5 days to expiryPut / call OI
—
dated and unknown snapshot sessions
Open interest
—
dated and unknown snapshot sessions
Volume
—
dated and unknown snapshot sessions
Chain
Click any strike for greeks, breakeven and the calculator| Calls | Puts | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| OI | Vol | IV | Δ | Last | Strike | Last | Δ | IV | Vol | OI |
| 1 | 3 | — | — | $13.06 | — | — | — | — | 0 | |
| 1 | 1 | 662.5% | 0.968 | $10.52 | $0.05 | — | — | 10 | 84 | |
| 0 | 1 | 511.5% | 0.933 | $4.70 | $0.03 | -0.048 | 438.5% | 1 | 192 | |
| 19 | 8 | 150.5% | 0.995 | $4.24 | $0.05 | -0.062 | 266.8% | 2 | 140 | |
| 69 | 10 | 117.8% | 0.944 | $2.85 | $0.12 | -0.113 | 161.4% | 90 | 671 | |
| 755 | 6 | 119.8% | 0.601 | $0.97 | $0.65 | -0.386 | 94.6% | 3 | 362 | |
| 1.2k | 387 | 113.4% | 0.186 | $0.16 | $2.30 | -0.899 | 82.7% | 22 | 1k | |
| 434 | 215 | 142.8% | 0.069 | $0.05 | $4.63 | -0.893 | 166.7% | 20 | 22 | |
| 587 | 521 | 211.7% | 0.078 | $0.14 | $13.82 | — | — | 1 | 0 | |
| 350 | 1 | 314.4% | 0.13 | $0.05 | $10.30 | — | — | 1 | 1 | |
| 296 | 10 | 418.9% | 0.133 | $0.05 | — | -0.974 | 274.5% | — | 0 | |
| 5 | 50 | 486.7% | 0.121 | $0.73 | — | -0.977 | 327.3% | — | 0 | |
| 94 | 1 | 566.3% | 0.131 | $0.60 | $22.82 | -0.979 | 373.1% | 2 | 0 | |
About this data
Each contract's last price, volume, greeks, implied volatility and open interest belongs to the snapshot session shown in its details; unknown means the provider omitted the timestamp. This chain has mixed snapshot sessions · Jan 20, 2026–Aug 14, 2026; 3 unknown. Cross-contract positioning totals are shown only when every returned row has the same known session. Bid and ask are not included on this plan.
In-the-money strikes are tinted, deepening toward the money, and the bar beside each open-interest figure scales to the heaviest strike shown.
Key facts
CIK
1285550
CUSIP
18507C103
13F (30d)
126 filings
123 filers
Visit website
Investor relations